Get started
Author

Giulio Meleleo

Observed name: Meleleo, Giulio
OpenAlex ID: A5099165961
A dynamic transmission model for assessing the impact of pneumococcal vaccination in the United States
2025 · Tufail M Malik, Kevin M Bakker, et al. · PLoS ONE · 17
Modelling the Epidemiological Impact of Different Adult Pneumococcal Vaccination Strategies in the United Kingdom
2025 · Rachel J. Oidtman, Giulio Meleleo, et al. · Infectious Diseases and Therapy · 13
PDF
Epidemiological Impact of Increasing Vaccination Coverage Rate and Re-Vaccination on Pneumococcal Disease in Older Adults in Germany
2025 · Oluwaseun Sharomi, Marion de Lepper, et al. · Vaccines · 7
PDF
Statistics for biquadratic covers of the projective line over finite fields
2016 · Elisa Lorenzo, Giulio Meleleo, et al. · Journal of Number Theory · 7
PDF
PCV13-Serotype Breakthrough Pneumococcal Disease in Infants Receiving High-Valency Conjugate Vaccines: Population-Level Modeling in France
2025 · Kevin M. Bakker, Rachel J. Oidtman, et al. · Infectious Diseases and Therapy · 3
Health impact and cost-effectiveness analysis of introducing a national immunization program with 21-valent versus 20-valent pneumococcal conjugate vaccines for adults ≥65 years of age in Denmark
2026 · Oluwaseun Sharomi, Rachel J. Oidtman, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 1
Impact of a 21-valent pneumococcal conjugate vaccine on pneumococcal disease incidence among adults 65–84 years of age in Belgium: An epidemiological modeling study
2026 · Yannick Vandenplas, Jonas Dobbelaere, et al. · Human Vaccines & Immunotherapeutics · 1
Predicting the Epidemiological Effects in the United Kingdom of Moving from PCV13 to PCV15 in the Routine Pediatric 1 + 1 Vaccination Schedule
2025 · Rachel J Oidtman, Natalie Banniettis, et al. · Vaccines · 1
PDF
Cyclicity of Quotients of Non-CM Elliptic Curves Modulo Primes
2015 · Giulio Meleleo · Contemporary mathematics - American Mathematical Society · 1
Projected epidemiological impact of lowering the adult pneumococcal vaccination age from 60 to 50 years in Germany
2026 · Oluwaseun Sharomi, Marion de Lepper, et al. · Figshare
Projected epidemiological impact of lowering the adult pneumococcal vaccination age from 60 to 50 years in Germany
2026 · Oluwaseun Sharomi, Marion de Lepper, et al. · Human Vaccines & Immunotherapeutics
PDF
Health impact and cost-effectiveness analysis of introducing a national immunization program with 21-valent versus 20-valent pneumococcal conjugate vaccines for adults ≥ 65 years of age in Denmark
2026 · Oluwaseun Sharomi, Rachel J. Oidtman, et al. · Figshare
Impact of a 21-valent pneumococcal conjugate vaccine on pneumococcal disease incidence among adults 65–84 years of age in Belgium: An epidemiological modeling study
2026 · Vandenplas, Yannick, Dobbelaere, Jonas, et al. · Figshare
P-58. Quantifying the impact of introducing a new adult-focused PCV in the United States
2025 · Kevin Bakker, Giulio Meleleo, et al. · Open Forum Infectious Diseases
P-617. Estimating Pediatric Breakthrough Disease from Pneumococcal Vaccines in France
2025 · Kevin Bakker, Rachel Oidtman, et al. · Open Forum Infectious Diseases
P-12. Evaluating the Epidemiological Impact of Lowering the Recommended Age for Adult Pneumococcal Vaccination in the United States
2025 · Kevin Bakker, Giulio Meleleo, et al. · Open Forum Infectious Diseases
PDF
P-11. Assessing the Epidemiological Impact of an Age-Based Pneumococcal Vaccine Recommendation in France
2025 · Kevin Bakker, Rachel Oidtman, et al. · Open Forum Infectious Diseases
PDF
P-52. Modeling the Epidemiological Impact of Different Adult Vaccination Strategies in the United Kingdom
2025 · Rachel Oidtman, Giulio Meleleo, et al. · Open Forum Infectious Diseases
PDF
Questions related to primitive points on elliptic curves and statistics for biquadratic curves over finite fields
2015 · Giulio Meleleo
Works count: 19
Citation count: 51
H-index: 4
I10-index: 2
Year
Topic
Type